Joris R de Groot
Joris R de Groot, MD, PhD, FESC is an expert in Cardiology at Amsterdam University Medical Center (Netherlands). As of October 2026, ScienceLeadR ranks Joris R de Groot in the top 1% of experts worldwide for Atrial Fibrillation and Arrhythmias, Cardiac. Joris R de Groot has authored 290 publications, the most recent in 2026, and is an investigator in 24 clinical trials, 4 of them ongoing. SLR score: 1,180 (community average: 125). How the SLR is computed.
LeadR Profile
Cardiology
Subspecialties: Hematology - Public Health - Pharmacy
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2001 - 2026
Number : 290
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
Clinical Studies 24
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Ongoing Clinical Trials
4 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Atrial Fibrillation Ablation and Autonomic Modulation Via Thoracoscopic Surgery 10 Year Follow up NCT06493591 — thoracoscopy, ganglia, autonomic, atrial fibrillation, therapeutics, ganglion cysts, ganglia, electrocardiography | N/A | Not yet recruiting | 2024 |
| In Hospital 24 Hour Observation of Syncope Patients NCT06472375 — syncope, emergencies, heart rate, heart, electrocardiography, ambulatory, emergency service, hospital, electrocardiography | N/A | Recruiting | 2023 |
| the Dutch GERAF Study NCT05337202 — research design, hemorrhage, atrial fibrillation, photoplethysmography, aged, smartphone, frailty | N/A | Active not recruiting | 2021 |
| Left Atrial Appendage Occlusion for AF Patients Unable to Use Oral Anticoagulation Therapy NCT04676880 — hemostatic disorders, anticoagulants, atrial appendage, safety, hemorrhage, blood, stroke, blood coagulation, hemostatics, atrial fibrillation, blood coagulation disorders, therapeutics, random allocation | N/A | Active not recruiting | 2021 |
LeadR Networks
Main global connection map